Skip to main content


Senior Research Associate

Lois Privor-Dumm, MBA, works to expand access to vaccines, trains advocates to speak on the value of immunization, and evaluates the use of policy to protect communities.

Contact Info

415 N. Washington Street, 5th Floor

Research Interests

vaccines; immunization policy; advocacy;  value of vaccines; vaccine hesitancy; India; low & middle income countries; adult vaccination; COVID-19; equity; global; Baltimore City; COVID-19 vaccination
Experiences & Accomplishments
University of South Carolina
As Sr. Advisor, Policy Advocacy & Communications and Director of Adult Immunization at the International Vaccine Access Center (IVAC), I focus on immunization policy issues across the life course in a broad range of countries. My research interests include understanding of the drivers of and barriers to country policies, characterizing country archetypes, stakeholder analysis, and factors impacting national vaccine decision-making and equitable uptake, with specific focus on pneumococcal, Hib, rotavirus, influenza and COVID-19 vaccines. More recently, I've focused on community engagement and vaccine acceptance in older minority populations in Baltimore City and preparation for COVID-19 vaccines in both the US and globally. I have worked in more than 70 countries to help accelerate equitable access to new and underutilized vaccines including Hib, pneumococcal, rotavirus, influenza and COVID-19 vaccines. Much of my focus has been in large countries, including India, Nigeria, Pakistan and Indonesia to support immunization decisions and work with local stakeholders to build an enabling environment for vaccines. My advocacy work focuses on both the broader value of vaccines and their contributions to the sustainable development goals, including the Value of Immunization Compendium of Evidence (VoICE) and the annual Pneumonia and Diarrhea Progress Report to provide advocates with evidence to drive change. My teaching focuses on vaccine policy and advocacy and I have trained hundreds of country-level professionals.

Prior to coming to Hopkins, I spent more than 15 years in the pharmaceutical industry working in a variety of commercial, operational, forecasting, market research and analysis, and R&D strategy roles in both human and animal health. I managed multiple strategies and initiatives for the launch of the first pneumococcal conjugate vaccine (PCV) in the US, and worked with countries in the Americas, Europe and the Middle East to introduce PCV, Hib vaccine and MenC vaccines.
Honors & Awards
Excellence in Baltimore City Public Health Practice 2021
Excellence in teaching, 2018, 2019
Select Publications
Selected publications
  • Privor-Dumm, L. Poland G, Barratt, J., Durrheim, D., Knoll, M., Vasudevan, P., Jit, M., Bonvehi, P., Bonanni, P., on behalf of the International Council on Adult Immunization. (2020) A Global Agenda for Adult Immunization in the Era of COVID-19: A Roadmap for Action. Vaccine. In press. 10.1016/j.vaccine.2020.06.082
  • Privor-Dumm, L. Vasudevan, P., Kobayaski, K., Gupta, J. (2020) Archetype Analysis of Older Adult Immunization Decision-Making and Implementation in 34 countries Vaccine, 38(26): 4170-4182. 10.1016/j.vaccine.2020.04.027
  • Ozawa, S., Privor-Dumm, L. A., Nanni, A., Durden, E., Maiese, B. A., Nwankwo, C. U., . . . Foley, K. A. (2014). Evidence-to-policy gap on hepatitis A vaccine adoption in 6 countries: Literature vs. policymakers' beliefs. Vaccine, 32(32), 4089-4096. doi:10.1016/j.vaccine.2014.05.026
  • Hajjeh RA, Privor-Dumm L, Edmond K, O'Loughlin R, Shetty S, Griffiths UK, Bear AP, Cohen AL, Chandran A, Schuchat A, Mulholland EK, Santosham M. Supporting new vaccine introduction decisions: lessons learned from the Hib Initiative experience.  Vaccine. 2010 Oct 8;28(43):7123-9
  • Levine OS, Hajjeh R, Wecker J, Cherian T, O'Brien KL, Knoll MD, Privor-Dumm L, Kvist H, Nanni A, Bear AP, Santosham M. A policy framework for accelerating adoption of new vaccines. Hum Vaccin. 2010 Dec;6(12):1021-4
Adult Vaccine Initiative
IPV Advocacy Efforts to Support Polio Endgame Strategies
Sustaining Access to Vaccines in India (SAVI)
Building an Enabling Environment for Vaccines in India (EEVI2)
Childhood Pneumonia and Diarrhea Advocacy /Stop Pneumonia Coalition
Gavi Pakistan Advocacy Support
Strengthening Advocacy for Immunization through Data (SAID)
Strengthening Immunization Advocacy Through Data: Country Specific - Indonesia
Vaccine Delivery IVAC Umbrella Grant (Multi-Project Grant)
Rotavirus Accelerated Vaccine Introduction Network
Sustaining Access for Vaccines in India (SAVI)
Baltimore City Influenza Vaccine Initiative Evaluation
Vaccine Advocacy Umbrella Grant